Moors & Cabot’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Moors & Cabot's ACLS Position: Q2 2026 in Review
Moors & Cabot increased its Axcelis (ACLS) stake by 7.1% in Q2 2026, buying an estimated $44.5K and bringing the position to 4,500 shares worth $853K. The position accounts for 0.03% of the portfolio, ranked #432.
Moors & Cabot first reported a position in ACLS in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.88M in Q2 2023. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Moors & Cabot held 4,500 shares of Axcelis worth $853K as of Q2 2026.
- Moors & Cabot bought 300 Axcelis shares in Q2 2026, an estimated $44.5K.
- Axcelis made up 0.03% of Moors & Cabot's portfolio in Q2 2026, its #432 holding.
- Moors & Cabot first reported a position in Axcelis in Q1 2021 and has held it in 22 quarters since.
- Moors & Cabot's Axcelis position peaked at $1.88M in Q2 2023.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.